Xermelo Approved for Carcinoid Syndrome Diarrhea
New Drugs , News / March 3, 2017

The FDA today approved Xermelo (telotristat ethyl) tablets in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled. Carcinoid syndrome is...

Odactra Approved for House Dust Mite Allergies
New Drugs , News / March 3, 2017

The FDA today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in peop...

Emflaza Approved for Duchenne Muscular Dystrophy
New Drugs , News / February 11, 2017

The FDA today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is ...

Skip to toolbar